slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 85,201-85,230
Pages 3,683
Rows per page 30
Component
85,201-85,230 of 110,471
28
The slide details the constraints of the experiment: 5 topics, 2 min prep, 5 min speech, and 3 audience members.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
36
The slide uses a hierarchical list to detail the research methodology.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
37
The chart highlights the 'Speech' phase with a box. SUDS is a standard clinical measure for anxiety.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Traction1 hit
38
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
46
The slide uses a pharmacokinetic line chart to demonstrate rapid absorption and a bulleted list to summarize clinical efficacy in GAD and panic models.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
47
The slide uses a bar chart to compare placebo vs BNC210 across two metrics: total number of symptoms and symptom intensity.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
50
The slide uses a process flow diagram to illustrate the clinical trial methodology.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
51
The slide details the research rigor behind the market sizing/revenue projections.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
53
Includes qualitative feedback from psychiatrists alongside key findings.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
59
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
05
Blue Water Vaccines | Results Presentation Deck | 15 slidesBlue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
The slide describes the mechanism of action for a specific vaccine candidate (BHN97ΔftsY).Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · AgitateLoop · Jobs To Be Done1 hit
13
The data shows ELISA absorbance results comparing vehicle (PBS) to the vaccine construct (LAV-D-M1) across four different pathogen serotypes/species.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
14
Blue Water Vaccines | Results Presentation Deck | 15 slidesBlue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
15
Blue Water Vaccines | Results Presentation Deck | 15 slidesBlue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · Action1 hit
02
Includes non-GAAP reconciliation footnotes.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Financial HighlightsLoop · Cost Of Inaction1 hit
06
Includes a non-GAAP reconciliation note regarding notable items.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Business Segment Performance1 hit
07
Includes footnotes referencing Appendix page 12.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Business Segment Performance1 hit
08
Includes footnotes reference to page 12.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Business Segment Performance1 hit
09
Includes footnotes regarding non-GAAP measures and specific reporting units.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Business Segment Performance1 hit
10
BNY Mellon | Results Presentation Deck | 18 slidesBNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Business Segment Performance1 hit
04
BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slidesBrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · AgitateLoop · Before After1 hit
11
The slide uses line charts with error bars to compare treatment effects across two subgroups (<=25 and >25 baseline ALSFRS-R).BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
12
The slide uses four line charts to demonstrate treatment effects on biomarkers, showing statistical significance markers.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
13
The slide uses color-coding to link specific biomarkers to biological pathways.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · Solution1 hit
08
The slide uses a split-layout to contrast internal goal achievement with external validation.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · ComplicationLoop · Cost Of Inaction1 hit
11
The slide uses a dual-pillar structure to present sustainability goals and quantitative targets for 2025, 2030, and 2050.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
14
The slide uses a numbered list format to define the three work fronts.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
17
The slide defines MACC and explains how to interpret the x-axis (reduction potential) and y-axis (cost).Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
18
MACC stands for Marginal Abatement Cost Curve.Braskem | ESG Presentation Deck | 54 slides · Braskem
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit